One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

This month, the U.S. Food and Drug Administration cleared two new oral antibiotics for use against gonorrhea: zoliflodacin ...

For the first time in decades, the US Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection is ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet. The study found that one ...

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhoea, according to a phase 3 clinical trial published in The Lancet. The study found ...

A new experimental scalp treatment called clascoterone has shown strong results in helping reduce male-pattern hair loss (also known as androgenetic alopecia, or AGA). Experts call the results ...

Please provide your email address to receive an email when new articles are posted on . Lifetime risk for hypertension is up to 90% among U.S. adults. Updated guidelines and a pipeline of novel drugs ...

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer-driving protein long considered impossible to target with drugs - a ...

A therapy that would once have been considered a feat of science fiction has reversed aggressive and incurable blood cancers in some patients, doctors report. The treatment involves precisely editing ...

Statistics show a clear spike in eight cancers in younger people, but that has brought a debate over whether many cases ever needed to be found. By Gina Kolata The statistics are incontrovertible: ...

Scientists have traced key gut-derived metabolites as they move from the intestine to the liver and into circulation, revealing how genetics, diet, and the microbiome combine to shape metabolic health ...

The STELLAR Phase 3 clinical trial found that a new treatment approach helped people with a tough-to-treat brain cancer, called grade 3 astrocytoma, live longer. The new treatment is a major step ...